Quality Sustainability in Pharma: Where Culture Becomes the True Competitive Edge
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.

Propanc Biopharma targets a February 2027 FIH Phase 1b start for PRP, running GMP manufacturing, bioanalytics, and HREC submission in parallel.

Cellipont and Xiogenix publish fill-finish performance data showing 17-fold scale consistency on the ARES™ X20+ platform for cell therapy manufacturing.

FDA expands sevabertinib's accelerated approval to first-line HER2-mutant NSCLC, reviewed concurrently with MHRA under Project Orbis.

CDSCO signals a shift to risk-based drug approvals, with Joint Drug Controller Dr. Ranga Chandrashekhar confirming a review of intervention points across approval pathways.
Latest edition
SPONSORED
SPONSORED

Sep 28
Oct 06
Oct 20From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
